Brussels, Belgium. April 26, 2017. The verdict is in, the Industrial Revolution 4.0 is underway and Additive Manufacturing (AM) is increasingly recognized as being integral in making it a firm reality. This was demonstrated in one presentation after another being given by industry experts over two tracks, Manufacturing and Medical, during the two-day Materialise World Summit in Brussels: April 20-21, 2017. What’s more, it became clear that collaboration is being increasingly embraced as the key to accelerating growth in the industry moving forward.
Siemens and Materialise have integrated additive manufacturing (AM) technology from Materialise into Siemens’ NX™ software, streamlining the design to manufacturing process for the rapidly growing universe of products being produced using AM (a.k.a. 3D printing).
Prior to this new FDA clearance, pediatric osteotomy planning was done using X-ray images to draw freehand surgical plans. Whether caused by trauma or natural-occurring, a deformity in the upper extremities in children can be difficult to fully visualize and plan for, and in cases where a child has lost the ability to rotate their forearm, surgical correction can be quite challenging.
Global 3D printing software and services provider Materialise is bolstering the Additive Manufacturing (AM) offering at the Manufacturing Technology Centre (MTC). Materialise is providing its world leading Magics 3D Print Suite software to the MTC, home of the National Centre for Additive Manufacturing in Coventry, after becoming one of the MTC’s newest members.
LEUVEN, Belgium--(BUSINESS WIRE)--Feb. 24, 2017-- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced its financial results for the fourth quarter and the year ended December 31, 2016.